Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.875 USD | -0.31% | -5.31% | -25.19% |
08/05 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
08/05 | Transcript : Zevra Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.19% | 205M | |
+9.26% | 72.5B | |
+13.69% | 9.11B | |
-12.85% | 5.07B | |
+59.61% | 5.01B | |
+1.60% | 3.85B | |
-17.54% | 2.46B | |
+19.77% | 2.44B | |
+24.62% | 2.27B | |
-27.46% | 2.26B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- HC Wainwright Cuts KemPharm's Price Target to $10 From $11, Reiterates Buy Rating